Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Generering av ett nytt dendritiskt cellvaccin med …
JoVE Journal
Immunology and Infection

This content is Open Access.

JoVE Journal Immunology and Infection
Generering av ett nytt dendritiskt cellvaccin med melanom och skivepitelcancerstamceller
Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Journal (Immunology and Infection)
Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Journal (Immunology and Infection)
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
 
Click here for the English version

Generering av ett nytt dendritiskt cellvaccin med melanom och skivepitelcancerstamceller

Article DOI: 10.3791/50561-v • 12:43 min • January 6th, 2014
January 6th, 2014 •
1, 1, 1, 1, 2, 3, 3, 3, 1, 2
1Department of Surgery, University of Michigan, 2Department of Internal Medicine, University of Michigan, 3Department of Otolaryngology, University of Michigan

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Utvärderas i syngeneic immunkompetenta värdar, cancer stamcell (CSC) baserade dendritic cell (DC) vaccin visat betydligt högre antitumör immunitet än traditionella DC vacciner pulsed med heterogena bulk tumör celler.

Tags

Cancerbiologi utgåva 83 Cancerstamcell (CSC) Dendritiska celler (DC) Vaccin Cancerimmunterapi antitumörimmunitet aldehyddehydrogenas
Read Article
Waiting X
Simple Hit Counter